This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

VIVUS Announces Scientific Presentations

MOUNTAIN VIEW, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, today announced the following scientific presentations:


SLEEP 2013: 27 th Annual Meeting of the Associated Professional Sleep Societies (APSS) June 1-5, 2013 Baltimore Convention Center, Baltimore, Maryland


Poster Presentation Date: Tuesday, June 4 th, 2013 from 4:00-6:00 PM Session Location: Exhibit Hall E, 100 level, Baltimore Convention Center Poster Number: 205 Abstract Number: 0867

Presentation Title

The Effects of Once-Daily Phentermine 15 mg and Topiramate Extended-Release 92 mg on Cardiometabolic Endpoints in Obese Patients With Obstructive Sleep Apnea

Authors: David H. Winslow, MD a; Charles H. Bowden, MD b; Karen DiDonato, RN, MSN b; Pamela A. McCullough, PhD a

Affiliations: aKentucky Research Group, Louisville, KY;  bVIVUS, Inc., Mountain View, CA


81 st Annual Scientific Meeting of the European Atherosclerosis Society Congress (EAS) June 2-5, 2013 LYON Congress Center, Lyon, France


Poster Presentation Date: Monday, June 3 rd and Tuesday, June 4 th, 2013 from 12:30-15:00 both days; Session Location: Center of the Exhibition area, Lyon Congress Centre


Poster Number: 430

Presentation Title

Weight Loss–Induced Improvements in Lipids in Overweight/Obese Subjects Treated With Phentermine and Topiramate Extended-Release

Authors: Hermann Toplak, MD a; Samuel Klein, MD b; Wesley W. Day, PhD c

Affiliations: aMedical University of Graz, Graz, Austria ; bWashington University School of Medicine, St Louis, Missouri, USA; cVIVUS, Inc., Mountain View, California, USA

About Qsymia

Qsymia ® (phentermine and topiramate extended-release) capsules CIV is approved in the U.S. and is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol.

The effect of Qsymia on cardiovascular morbidity and mortality has not been established. The safety and effectiveness of Qsymia in combination with other products intended for weight loss, including prescription and over-the-counter drugs, and herbal preparations, have not been established.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community


Chart of I:DJI
DOW 16,069.51 -305.25 -1.86%
S&P 500 1,916.36 -34.77 -1.78%
NASDAQ 4,670.1420 -63.3550 -1.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs